跳至主要内容
临床试验/NL-OMON50285
NL-OMON50285已完成不适用

Ocular vestibular evoked myogenic potentials in patients with myasthenia gravis - oVEMPs in patients with myasthenia gravis

eids Universitair Medisch Centrum0 个研究点目标入组 102 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Cross-sectional study (objective 1)
  • Patients with MG:
  • * Patient is legally capable
  • * Definitive diagnosis of MG defined as the presence of a typical history and
  • at least one positive ancillary test,
  • including edrophonium testing, RNS, and serum autoantibodies
  • (anti-acetylcholine receptor [AChR], anti-muscle
  • specific tyrosine kinase [MuSK]).
  • Healthy controls:
  • * Healthy control is legally capable
  • * No diagnosis of MG
  • * Absence of disease that involves eye-muscle function or any other muscle
  • Controls with other neuromuscular diseases:
  • * Patient is legally capable
  • * No diagnosis of MG
  • * Definite diagnosis of other neuromuscular disease
  • Controls non-neuromuscular diseases that can cause diplopia:
  • * Patient is legally capable
  • * No diagnosis of MG
  • * No other neuromuscular disease
  • * Definite diagnosis that can cause diplopia
  • * Presence of diplopia
  • Longitudinal study (objective 2)
  • Patients with the clinical suspicion of MG:
  • * Patient is legally capable
  • * MG is in the differential diagnosis
  • * No definitive diagnosis of MG'
  • Neostigmine study (objective 3)
  • Patients who undergo an acetylcholinesterase inhibitor (neostigmine) test within
  • routine clinical care:
  • * Patient is legally capable
  • * MG is in the differential diagnosis
  • * Patient undergoes neostigmine test for diagnostic purposes

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:, * Patients who are legally incapable
  • * Patients who are under the age of 16
  • * Patients with known vestibulo-cochlear disorders

研究者

相似试验